1.Chinese Tuina: challenge of evidence-based medicine and development strategy
Jun HU ; Juantao YAN ; Min FANG
Journal of Integrative Medicine 2005;3(6):429-31
Evidence-based medicine (EBM), which aims to get the best evidence from medical research, is a growing international movement in health care. Because of this new shift in medical practice, great attention should be paid to how to introduce EBM into Chinese Tuina, and this is a good opportunity for the development of Chinese Tuina. To adopt EBM will be beneficial to developing Chinese Tuina, improving clinical research, renewing education mode and getting more academic achievement. So it is necessary to establish a new experimental methodology combined with EBM in order to get great progress in Chinese Tuina.
4.Reliability and validity of Stanford Presenteeism Scale Chinese version.
Fang ZHAO ; Jun-ming DAI ; Shi-yong YAN
Chinese Journal of Industrial Hygiene and Occupational Diseases 2010;28(9):679-682
Adult
;
Efficiency
;
Female
;
Humans
;
Male
;
Middle Aged
;
Psychometrics
;
Surveys and Questionnaires
5.Effects of irbesartan on the expression of CTGF and MT1-MMP in high glucose-induced rat glomerular mesangial cells
Fang YAO ; Zhe YAN ; Yonghong SHI ; Jun HAO ; Huijun DUAN
Chinese Pharmacological Bulletin 1986;0(04):-
Aim To investigate the effects of Ang Ⅱ receptor antagonist irbesartan on the expressions of connective tissue growth factor(CTGF) and membrane-type 1 matrix metalloproteinase(MT1-MMP) in high glucose-cultured rat glomerular mesangial cells(GMCs).Methods High concentration glucose and irbesartan were used to stimulate the cultured rat GMCs in vitro.The mRNA and protein expressions of CTGF and MT1-MMP were detected with semi-quantitative RT-PCR and Western blot.The secreted collagen Ⅳ in the supernatants of the GMCs was detected by enzyme-linked immunoadsorbent assay(ELISA).Results Compared with control group,the expressions of CTGF were continuously increased in GMCs under high concentration glucose medium;otherwise the mRNA and protein levels of MT1-MMP in GMCs were decreased in a time-dependent manner at the same time.These changes were accompanied by increased secretion of collagen Ⅳ.Irbesartan could inhibit those changes induced by high glucose.Conclusions High glucosecould induce the expression of CTGF and inhibit the expression of MT1-MMP in GMCs.Irbesartan could inhibit the secretion of ECM in GMCs under high concentration glucose medium,partly by regulating the expressions of CTGF and MT1-MMP.
6.Study on HPLC Characteristic Fingerprints of Lavandula Angustifolia
Chenyang LI ; Wei TAN ; Yan CHEN ; Jun ZHAO ; Fang XU
Chinese Journal of Information on Traditional Chinese Medicine 2015;(4):87-90,91
Objective To establish the fingerprints of 20 batches of Lavandula Angustifolia by HPLC. Methods The determination was performed on a Phenomenex ODS-A column (250 mm× 4.6 mm, 5 μm). The mobile phase was in gradient elute mode with a mixture consisting of acetonitrile and 0.036 mol/L phosphate acid solution. The flow rate was 1.0 mL/min. The temperature was 30 °C. The determine wavelength was 350 nm. The fingerprints of 20 batches of Lavandula Angustifolia were compared and classified by similarity evaluation, cluster analysis, and principal composition analysis. Results Totally 10 chromatographic peaks were extracted as the common peaks of Lavandula Angustifolia, and 2 peaks were identified. The similarity degrees of the 20 batches of Lavandula Angustifolia were above 0.9. All the batches of Lavandula Angustifolia were classified into 3 categories. Conclusion The method is simple and reproducible, and can be used for the standardization and quality control of Lavandula Angustifolia.
7.The effects of imatinib mesylate on immune globulin and T cell subset in patients with chronic myelocytic leukemia.
Rui-rui GUI ; Yan-li ZHANG ; Bai-jun FANG
Chinese Journal of Hematology 2012;33(3):225-226
Adult
;
Aged
;
Benzamides
;
therapeutic use
;
Case-Control Studies
;
Female
;
Humans
;
Imatinib Mesylate
;
Immunoglobulins
;
metabolism
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
drug therapy
;
immunology
;
Male
;
Middle Aged
;
Piperazines
;
therapeutic use
;
Pyrimidines
;
therapeutic use
;
T-Lymphocyte Subsets
8.Analysis of the clinical data of 2843 patients with thyroid nodules
Jun LI ; Guijun QIN ; Yushan YAN ; Fang WANG ; Xiaojing WANG
Chinese Journal of Endocrinology and Metabolism 2012;28(10):802-805
Objective To analyze the clinical and pathological characteristics of thyroid nodules.Methods A retrospective analysis of the clinical data of 2843 Han patients with thyroid nodules from January 2009 to June 2011 in Henan province was performed.Results The most high-risk of thyroid nodule resided in the group aged 45-54.The main pathological manifestation was simple nodular goiter.The rate of preoperative misdiagnosis was 2.4%.22.1% of the patients with thyroid nodules showed abnormal thyroid function,which was mainly as subclinical thyroid dysfunction.The positive rate of thyroid peroxidase antibody (TPOAb) in patients with thyroid nodule was 19.8% while that of thyroid globulin antibody (TgAb) was 20.0%.Among all 2843 subjects,the prevalence of differentiated thyroid carcinoma (DTC) was 28.8%,and the incidence of DTC was accompanied by raised TSH levels.The prevalence of DTC exceeded 40% in patients aged between 25 to 34 as well as more than 74 years old.The prevalence of DTC was up to 33.8% in TgAb positive patients.There was no difference in TPOAb levels between DTC patients and non DTC patients (P =0.406),but the TgAb level in patients with DTC was significantly higher than that of non DTC patients (P =0.033).Conclusion Thyroid nodule patients aged 25-34 or older than 74 formed high-risk groups of DTC.The serum TSH level and TgAb level were positively correlated with the risk of DTC.
9.Evaluation of the effectiveness by interventional treatment for carotid arterial cavernous sinus fistula
Lian ZHAO ; Zhijian WU ; Yan JIANG ; Jun FANG ; Xiaojiang ZHU
Journal of Interventional Radiology 2001;0(06):-
Objective To summerize the clinical experience of 23 cases of carotid cavernous fistula(CCF) and discuss the treatment strategy. Methods Retrospectively analyzed 23 patients(11 males and 12 females) of CCF,including 14 patients with Barrow type A,1 with type B,1 with type C and 7 with type D. Results Vascular approach for embolization was undertaken in 20 cases by transarterial access and 2 via venous route while 1 case was given up. Among them,9 cases obtained complete occlusion by simple balloon embolization and 5 were treated by direct occlusion of internal carotid artery. Another 5 cases used NBCA glue for the occlusion,1 case was embolized by gelatin-sponge particulates combined with compression of carotid artery,2 cases were treated by coil embolization of cavernous sinus and 1 case was only managed by carotid compression maneuver. We achieved satisfactory clinical results with 21 patients cured and 2 patients improved. Conclusion Complexity and refractory are the characteristic of CCF,and endovascular treatment should be the major choice of treatment. (J Intervent Radiol,2006,15: 323-326)
10.Analysis of related factors of recurrence after myomectomy
jun-yan, ZHU ; wei-ping, LI ; fang-sun, LIU
Journal of Shanghai Jiaotong University(Medical Science) 2006;0(02):-
Objective To study the related factors of recurrence after myomectomy. Methods The clinical data of 441 cases with myomectomy were collected. The age at the time of operation, body mass index(BMI), preoperative parity, and the location, size and number of myomas were recorded, and the postoperative recurrence rate was calculated. Univariate and multivariate analysis were performed for possible factors related to recurrence. Results The average time of follow-up was(37.79?18.64) months. Recurrence was found in 125 cases, and 5-year cumulative rate of recurrence was 38.9%. The age at the time of operation, BMI, number of myomas and preoperative parity were related factors of recurrence(P